Nilotinib - Novartis Pharmaceuticals Corporation
At a glance
- Drug Originator Novartis Pharmaceuticals Corporation
- Drug Class Antineoplastics; Benzamides; Fluorinated hydrocarbons; Imidazoles; Ketones; Pyridines; Pyrimidines; Small molecules
- Mechanism of Action Bcr-abl tyrosine kinase inhibitors; Platelet derived growth factor alpha receptor antagonists; Platelet-derived growth factor beta receptor antagonists; Proto oncogene protein c-kit inhibitors
- USA Patent Applicants NOVARTIS
- USA Patents 13
- NDAs 1
- International Patents 286
- Patent Applications 4,662

Disclaimer